LeMaitre George W 4

Accession 0001193125-25-319553

CIK 0001158895other

View on SEC.gov Company Profile

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 6:14 PM ET

Size

37.7 KB

Accession

0001193125-25-319553

Insider Transaction Report

Form 4

Period: 2025-12-11

LEMAITRE VASCULAR INCLMAT

LeMaitre George W

DirectorChairman and CEO10% Owner

Transactions

Exercise/Conversion
Common Stock
2025-12-11+54→ 1,670,159 total
Tax Payment
Common Stock
2025-12-11$83.36/sh−652$54,351→ 1,669,507 total
Exercise/Conversion
Common Stock
2025-12-12$37.29/sh+5,155$192,230→ 1,674,662 total
Exercise/Conversion
Common Stock
2025-12-12$48.60/sh+7,733$375,824→ 1,682,395 total
Exercise/Conversion
Common Stock
2025-12-12$47.19/sh+7,075$333,869→ 1,689,470 total
Exercise/Conversion
Common Stock
2025-12-12$54.65/sh+6,182$337,846→ 1,695,652 total
Gift
Common Stock
2025-12-12−12,100→ 1,683,552 total
Award
Common Stock
2025-12-12+12,100→ 33,400 total(indirect: By Trust)
Exercise/Conversion
Common Stock
2025-12-12+39→ 1,683,591 total
Tax Payment
Common Stock
2025-12-12$84.00/sh−663$55,692→ 1,682,928 total
Exercise/Conversion
Dividend Equivalent Rights
2025-12-11−54→ 0 total
→ Common Stock (54 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-12−5,155→ 0 total
Exercise: $37.29From: 2020-12-02Exp: 2027-12-02→ Common Stock (5,155 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-12−7,733→ 0 total
Exercise: $48.60From: 2021-12-11Exp: 2028-12-11→ Common Stock (7,733 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-12−7,075→ 9,194 total
Exercise: $47.19From: 2022-12-12Exp: 2029-12-12→ Common Stock (7,075 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-12−6,182→ 14,191 total
Exercise: $54.65From: 2023-12-08Exp: 2030-12-08→ Common Stock (6,182 underlying)
Exercise/Conversion
Dividend Equivalent Rights
2025-12-12−39→ 41.931 total
→ Common Stock (39 underlying)

Footnotes (12)

[F1]Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
[F10]This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.
[F11]These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
[F12]These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
[F2]These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/11/2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
[F3]Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
[F4]These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.
[F5]These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
[F6]These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
[F7]These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
[F8]Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero.
[F9]This option is fully vested and exercisable.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

LEMAITRE VASCULAR INC

CIK 0001158895

→

Entity typeother

Related Parties

filerCIK 0001365737

Filing Metadata

Form type: 4
Filed: Dec 14, 7:00 PM ET
Accepted: Dec 15, 6:14 PM ET
Size: 37.7 KB

View on SEC.gov